Defining Enthesitis in Spondyloarthritis by Ultrasound: Results of a Delphi Process and of a Reliability Reading Exercise

dc.authorid0000-0001-5352-8683
dc.authorid0000-0001-8193-9471
dc.authorid0000-0002-9156-5028
dc.authorid0000-0003-0017-0096
dc.authorid0000-0001-5592-724X
dc.authorid0000-0003-1526-4052
dc.authorid0000-0002-3181-4598
dc.contributor.authorTerslev, L.
dc.contributor.authorNaredo, E.
dc.contributor.authorIagnocco, A.
dc.contributor.authorBalint, P. V.
dc.contributor.authorWakefield, R. J.
dc.contributor.authorAegerter, P.
dc.contributor.authorAydin, S. Z.
dc.date.accessioned2025-05-10T19:53:29Z
dc.date.issued2014
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description.abstractObjective To standardize ultrasound (US) in enthesitis. Methods An initial Delphi exercise was undertaken to define US-detected enthesitis and its core components. These definitions were subsequently tested on static images taken from spondyloarthritis patients in order to evaluate their reliability. Results Excellent agreement (>80%) was obtained for including hypoechogenicity, increased thickness of the tendon insertion, calcifications, enthesophytes, erosions, and Doppler activity as core elementary lesions of US-detected enthesitis. US definitions were subsequently obtained for each elementary component. On static images, the intraobserver reliability showed a high degree of variability for the detection of elementary lesions, with kappa coefficients ranging from 0.13-1. The interobserver kappa values were variable, with the lowest kappa coefficient for enthesophytes (0.24) and the highest coefficient for Doppler activity at the enthesis (0.63). Conclusion This is the first consensus-based US definition of enthesitis and its elementary components and the first step performed to ensure a higher degree of homogeneity and comparability of results between studies and in daily clinical work.
dc.description.sponsorshipAbbVie; MSD; Pfizer; Roche; Bristol-Myers Squibb; UCB; Abbott
dc.description.sponsorshipDr. Aydin has received consultancy fees, speaking fees, and/or honoraria (less than $10,000 each) from AbbVie, MSD, and Pfizer. Dr. Hammer has received consultancy fees, speaking fees, and/or honoraria (less than $10,000 each) from AbbVie, Pfizer, and Roche. Dr. Bruyn owns stock or stock options in Vertex. Dr. Filippucci has received consultancy fees, speaking fees, and/or honoraria (less than $10,000 each) from AbbVie, Bristol-Myers Squibb, MSD, UCB, and Pfizer. Dr. Mandl has received consultancy fees, speaking fees, and/or honoraria (less than $10,000 each) from Abbott, AbbVie, and Pfizer. Dr. D'Agostino and Dr. Wakefield are authors of an ultrasound book, for which they have received royalties.
dc.identifier.doi10.1002/acr.22191
dc.identifier.endpage748
dc.identifier.issn2151-464X
dc.identifier.issn2151-4658
dc.identifier.issue5
dc.identifier.pmid24151222
dc.identifier.scopus2-s2.0-84899072215
dc.identifier.scopusqualityQ1
dc.identifier.startpage741
dc.identifier.urihttps://doi.org/10.1002/acr.22191
dc.identifier.urihttps://hdl.handle.net/20.500.14730/12753
dc.identifier.volume66
dc.identifier.wosWOS:000334658600013
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherWiley-Blackwell
dc.relation.ispartofArthritis Care & Research
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WOS_20250302
dc.subjectPower Doppler Ultrasonography
dc.subjectAnkylosing-Spondylitis
dc.subjectEntheseal Insertions
dc.subjectSonographic Analysis
dc.subjectPsoriatic-Arthritis
dc.subjectEnthesopathy
dc.titleDefining Enthesitis in Spondyloarthritis by Ultrasound: Results of a Delphi Process and of a Reliability Reading Exercise
dc.typeArticle

Dosyalar

Orijinal paket

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
12753.pdf
Boyut:
129.78 KB
Biçim:
Adobe Portable Document Format